Publication | Closed Access

Low-dose oral copper treatment changes the hippocampal phosphoproteomic profile and perturbs mitochondrial function in a mouse model of Alzheimer's disease

Alzheimer's DiseaseMedicineDementiaBioactive MetalNeurochemical BiomarkersNeurologyNeuroscienceNeurodegenerationPerturbs Mitochondrial FunctionHippocampal Phosphoproteomic ProfilePharmacologyMouse ModelOxidative Stress